Epilepsy treatment in neuro-oncology: A rationale for drug choice in common clinical scenarios
José Manuel Sánchez-Villalobos(Santa Lucía University General Hospital), M. Alcaráz, Ángel Aledo‐Serrano, Irene Villegas-Martínez(Santa Lucía University General Hospital), Mohd. Farooq Shaikh(University of Mumbai)
Cited by 19
Related Papers
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
|Frontiers in Neuroscience|2018|318
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
|Cells|2020|257
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
|European Journal of Pharmacology|2019|175
Cytotoxicity and Antiproliferative Activities of Several Phenolic Compounds Against Three Melanocytes Cell Lines: Relationship Between Structure and Activity
|Nutrition and Cancer|2004|161
Alcohol Use Disorder, Neurodegeneration, Alzheimer’s and Parkinson’s Disease: Interplay Between Oxidative Stress, Neuroimmune Response and Excitotoxicity
|Frontiers in Cellular Neuroscience|2020|160